# BioTrack Capital

> BioTrack Capital is a VC fund backing Biotechnology and Health Care. See 93 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Shanghai, China
- Total investments: 93
- Last investment: Jun 2026
- Lead investor: 32%
- Last updated: Aug 2026
- Website: http://www.biotrackcapital.com/

BioTrack Capital is a VC fund in Shanghai focused on Biotechnology and Health Care. BioTrack Capital invests in early and growth stage companies within life sciences, healthcare technology, biotechnology and related high-tech sectors, providing capital and investment support for innovation. The firm evaluates scientific and commercial potential of ventures and structures financings aimed at advancing technologies from earlyresearch to market engagement. Its activities include sourcing opportunities, conducting due diligence, and working with founders and management teams to align growth strategies with investor objectives. BioTrack Capital also participates in funding rounds alongside co-investors to support development of novel healthcare and tech solutions. The company engages with portfolio companies through strategic interaction and monitoring of progress toward business milestones.

## Contacts

5 contacts available for BioTrack Capital. Shizune tracks 4 team members at BioTrack Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/biotrack-capital?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $16M–$168M |
| Series A | $14M–$45M |
| Series B | $15M–$147M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 33 | 35% |
| Health Care | 32 | 34% |
| Medical | 24 | 26% |
| Pharmaceutical | 13 | 14% |
| Manufacturing | 12 | 13% |

40 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 28 | 30% |
| Series B | 25 | 27% |
| Seed | 14 | 15% |
| Angel | 5 | 5% |
| Venture - Series Unknown | 5 | 5% |

8 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 58 | 62% |
| United States | 8 | 9% |
| Singapore | 1 | 1% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Feng Tao | Co-Founder & Partner | 0 | https://shizune.co/investors/profile/feng-tao-481b |
| Jiacong Guo | Executive Director | 3 | https://shizune.co/investors/profile/jiacong-guo |
| Kevin (Penghui) Chen | Founder & Partner | 7 | https://shizune.co/investors/profile/kevin-penghui-chen |
| Zhang Ye | Project Manager | 1 | https://shizune.co/investors/profile/zhang-ye-1d05 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Zhiyue Space Intelligence | Zhiyue Space Intelligence specializes in robotic brain and brain systems. |  | Angel | Jun 23, 2026 |  |
| Taiyi Quantum | Taiyi Quantum is dedicated to encouraging innovation in the distribution and implementation of quantum computing technology, as well as developing sophisticated quantum algorithms and delivering tailored computing solutions for businesses and research institutes. | $44.4M | Seed | Jun 17, 2026 |  |
| Carbonology | Carbonology is a carbon capture company that produces fuels, chemicals, and polyesters. |  | Series A | Jun 12, 2026 |  |
| Carbon Life | Carbon Life is a carbon sequestration technology developer. It is mainly engaged in carbon emission reduction, carbon conversion, carbon capture, carbon sequestration technology research and development. |  | Series A | Jun 12, 2026 |  |
| Carbonology | Carbonology is a carbon capture company that produces fuels, chemicals, and polyesters. |  | Seed | Jun 12, 2026 |  |
| Dongsheng Fusion | Dongsheng Fusion is a magnetic confinement fusion technology company that develops miniaturized fusion power plant technology. |  | Seed | May 27, 2026 |  |
| Aureka Biotechnologies | Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in order to conquer sickness. | $35M | Series A | Apr 28, 2026 |  |
| Syneron | Syneron was founded by Sinovation Ventures and is dedicated to using artificial intelligence and biotechnology to address two significant global challenges: the efficient development of novel biological therapies and the low-carbon manufacture of biochemicals. | $150M | Series B | Mar 31, 2026 |  |
| GasGene | GasGene ferments industrial waste gas to generate bulk chemicals. | $14.5M | Venture - Series Unknown | Mar 23, 2026 |  |
| PrinoPharma | PrinoPharma focuses on developing novel druggable sites targeting difficult-to-drug or existing druggable targets. | $14.5M | Angel | Mar 10, 2026 |  |

10 of 93 investments shown.

## Co-investors
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund, 13 deals together
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund, 9 deals together
- [Sinovation Ventures](https://shizune.co/investors/profile/sinovation-ventures) — VC Fund, 7 deals together
- [CASH Capital](https://shizune.co/investors/profile/cash-capital) — VC Fund, 6 deals together
- [HSG](https://shizune.co/investors/profile/hsg-cap) — VC Fund, 6 deals together
- [Legend Capital](https://shizune.co/investors/profile/legend-capital) — VC Fund, 6 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [Health Care Investors in Asia](https://shizune.co/investors/health-care-investors-asia)
- [Health Care VC Funds in Asia](https://shizune.co/investors/health-care-vc-funds-asia)
- [Health Care Investors in China](https://shizune.co/investors/health-care-investors-china)
- [Health Care VC Funds in China](https://shizune.co/investors/health-care-vc-funds-china)
- [Medical Investors in Asia](https://shizune.co/investors/medical-investors-asia)
- [Medical VC Funds in Asia](https://shizune.co/investors/medical-vc-funds-asia)

## FAQ

### What does BioTrack Capital invest in?

BioTrack Capital invests primarily in Biotechnology, Health Care and Medical startups, most often at Series A and Series B stage. Most of the 93 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is BioTrack Capital's check size?

BioTrack Capital typically joins rounds of $16M–$168M at Seed, $14M–$45M at Series A and $15M–$147M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds BioTrack Capital participates in.

### How do I contact BioTrack Capital?

Public channels for BioTrack Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at BioTrack Capital?

The team at BioTrack Capital includes Feng Tao (Co-Founder & Partner), Jiacong Guo (Executive Director) and Kevin (Penghui) Chen (Founder & Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co